Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Auxilium Pharmaceuticals to Merge with Canadian Biotechnology Company QLT

26/06/2014 by

W1siziisijiwmtqvmtavmjgvmtuvmzuvntqvmjc4l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

Auxilium Pharmaceuticals, Inc., a fully integrated specialty bio pharmaceutical company, and QLT Inc., a Canadian-based biotechnology company focused on developing innovative orphan ophthalmology products, today announced that they have entered into a definitive agreement under which Auxilium plans to merge with QLT. The transaction is expected to drive shareholder value creation by accelerating Auxilium’s ongoing transformation into a leading diversified North American specialty bio pharmaceutical company. As a result of the merger, Auxilium expects to have an expanded corporate platform that includes focused investments in research and development and the continued pursuit of new products and M&A due to cost and tax synergies. The companies also intend to continue to pursue a potential partnering agreement for QLT’s promising late-stage retinoid program.

Under the terms of the agreement, a wholly-owned subsidiary of QLT will be merged with and into Auxilium. QLT will remain incorporated in British Columbia, Canada, and will be renamed “New Auxilium.” Current shareholders of Auxilium will receive 3.1359 QLT shares for each Auxilium share, subject to certain adjustments. For QLT shareholders, the transaction represents a 25% premium based on a calculation of the closing NASDAQ stock prices of Auxilium and QLT on June 25, 2014, the last trading day prior to the announcement of the merger. When completed, Auxilium shareholders will own approximately 76% of the combined entity on a fully diluted basis, and current QLT shareholders will own approximately 24%, subject to certain adjustments.

This article has been extracted from http://www.marketwatch.com, please click on this link to read the article in full http://www.marketwatch.com/story/auxilium-pharmaceuticals-to-merge-with-canadian-biotechnology-company-qlt-2014-06-26

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtyvmtivmdivmtavmdcvntcvotkwl2j1c2luzxnzigludgvsbglnzw5jzs5qcgcixsxbinailcj0ahvtyiisijm4mhgxmdajil1d

Annual growth rate for BI market set at 8.4%

2016-12-02 10:00:00 +0000

A new report has suggested that the compound average growth rate (CAGR) for the business intelligence (BI) market between 2016 and 2021 is likely to be around 8.4 per cent. The latest publication, named Global Business Intelligence Market by Mobile BI, Cloud BI, and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015-2021, said that 2015 saw the global BI sector valued at $16.33 billion. By 2021, this is expected t...

W1siziisijiwmtyvmtevmzavmtavmjavntuvndgzl09jbcbyawcgc2vhlmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Crisis in oil and gas industry nears turning ...

2016-11-30 10:00:00 +0000

A new report has suggested that the current crisis being experienced by the gas and oil industry is nearing a turning point. As part of the 25th Oil and Gas Survey, it was found that although two-thirds of firms had cut employment levels in 2015, the speed at which these cuts are occurring has slowed. In addition, other methods of saving have been utilised to drive operational costs down. Amongst the firms questioned, it was found that 67 per cent of bu...